Kihleo
Kihleo provides a biosensor integrated directly into incontinence products that continuously measures electrochemical and optical parameters to detect early signs of urinary tract infections in elderly care residents. The system analyzes trends over time and alerts healthcare staff through an app or existing health systems, enabling earlier intervention and reducing unnecessary antibiotic use. This addresses the unreliability of traditional urine dipstick tests, which show just 39% specificity in elderly patients.
- Healthcare Technology
- Medical Devices
- Internet of Things
- Digital Health
- Hardware
- Data & Analytics
- Software Only
Funding
Founders
Founder details are not available yet.
Product
Problem
Urinary tract infections are among the most frequent infections in Danish nursing homes, yet current urine dipstick tests are unreliable in elderly patients, with one study finding a specificity of just 39%. This leads to both unnecessary antibiotic treatment and missed infections, especially in residents with dementia or other age-related conditions that make it difficult for them to express symptoms, with hospital-acquired UTIs estimated to cost Danish society up to 400 million DKK annually.
Solution
Kihleo provides a biosensor integrated directly into incontinence products that continuously measures electrochemical and optical parameters without disrupting the resident's daily life. The system calculates and monitors patterns over time to build a picture of trends, detecting early signs of urinary tract infection development. When a relevant trend is identified, healthcare staff receive a clear follow-up signal through Kihleo's app or their existing health systems. The solution supplements the subjective observations of care staff with objective, data-based signals, enabling earlier intervention before conditions become severe. Clinical assessment and decisions about further action remain with the healthcare personnel, supporting more timely and qualitative care while reducing unnecessary antibiotic use.
Target Audience
Primary customers are Danish municipalities and care providers operating nursing homes and home care services for elderly residents, particularly those caring for individuals with dementia or communication difficulties.
Features
- Biosensor integrated into incontinence products measuring electrochemical and optical parameters continuously
- Trend analysis system that monitors patterns over time to identify developing infections
- Clear follow-up signals delivered via dedicated app or integration with existing health systems
- Objective data supplementation to support staff in detecting signs that are otherwise difficult to spot in a busy workday
- Non-invasive design that does not change the resident's daily routine